NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Major Upgrade for Citius Oncology: Lymphir Launch Anticipation

Citius upgraded to Buy ($6). Lymphir launches in Q4 at high prices ($300K). Sales should jump fast starting in 2026.

Major Upgrade for Citius Oncology: Lymphir Launch Anticipation
Credit: Citius Oncology
Already have an account? Sign in.
09/23/2025 · 8:42 AM
CTOR
/ Read more

Feed↓

Nektar Wins $90 Million Verdict Against Eli Lilly Over Rezpeg Partnership
09/25/2026 · 6:09 PM

Nektar Wins $90 Million Verdict Against Eli Lilly Over Rezpeg Partnership

California jury found Lilly breached good faith in the 2017 rezpeg deal and awarded Nektar $90 million plus interest. Lilly plans to appeal.

/ Subscriber only
SK Hynix’s Solidigm Weighs IPO That Could Value the Storage Unit at $150 Billion
Featured/ 09/25/2026 · 1:27 PM

SK Hynix’s Solidigm Weighs IPO That Could Value the Storage Unit at $150 Billion

Reuters: Solidigm is weighing a US IPO as early as 2027 that could value the AI storage business at $150 billion and raise $15 billion.

/ Subscriber only
Zscaler Stock Slides After CRO Change as Analysts Call Handoff Low-Risk
09/25/2026 · 12:31 PM

Zscaler Stock Slides After CRO Change as Analysts Call Handoff Low-Risk

Investors focused on Zscaler’s sales engine after Tackett’s CRO promotion. Analysts say the change continues the current go-to-market plan.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe